For now, Alex Rodriguez's latest steroid saga is the business of Major League Baseball investigators and federal agents probing the South Florida connections reported to have supplied the Yankees' slugger — and many other pro athletes — with performance-enhancing drugs.

Once that process plays out, the Yankees will have their turn at bat.

Their chances of recouping part of the $114 million remaining on A-Rod's contract through 2017 are linked to the "active investigation" acknowledged in an MLB statement. There's also the matter of contract language specific to items such as treatment administered without the club's knowledge or consent — if it can be proven — or if any laws were violated.

In touting its "strong working relationships" with federal and local authorities, MLB said in its statement Tuesday that "only law enforcement officials have the capacity to reach those outside the game who are involved in the distribution of illegal performance-enhancing drugs."

However it plays out, there is an increasing feeling around baseball that Rodriguez, 37, already might have played his final game in pinstripes.

Through a public relations firm, Rodriguez denied having had any relationship with Anthony Bosch, the head of a now-defunct, Miami-based, anti-aging clinic at the center of the Miami New Times' explosive report Tuesday alleged to have trafficked in steroids.

Based on admissions from former employees and records it said came from the shuttered clinic, Biogenesis of America, the New Times' report claimed that A-Rod had purchased human growth hormone and other banned substances from 2009 through last season.